載入...
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
A teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia was hospitalized and recovered in 15 days. The immunophenotyping analysis of peripheral blood cells was performed in two time points: the first was 1 month before (pre-infection) while the second was during COVID-19 pneumonia...
Na minha lista:
| 發表在: | J Neuroimmunol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361089/ https://ncbi.nlm.nih.gov/pubmed/32688146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2020.577323 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|